IGM Biosciences, Inc. Asset Impairment Charges
IGM Biosciences, Inc. reported Asset Impairment Charges of $31.00 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-07-31
- IGM Biosciences, Inc. asset impairment charges for the quarter ending 2025-06-30 was $31.00M.
- IGM Biosciences, Inc. asset impairment charges for the quarter ending 2025-03-31 was $21.90M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month |
|---|---|---|
| 2025-06-30 | $31.00M 10-Q · filed 2025-07-31 | $52.90M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $21.90M 10-Q · filed 2025-07-31 |